Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surfx Technologies is a specialized provider of atmospheric pressure plasma systems designed for surface cleaning and activation. Founded in 1999 as a spin-off from UCLA, the company developed the patented Atomflo™ technology, which allows for high-precision surface treatment without the need for vacuum chambers. In the life sciences and medical device sectors, Surfx's systems are used to improve the bonding of polymers, metals, and glass, which is essential for manufacturing catheters, stents, and microfluidic diagnostic chips. Their technology enhances the wettability and adhesion of biocompatible coatings and adhesives, ensuring the structural integrity of critical medical components. The company serves a global market, providing both handheld and automated plasma solutions for R&D and high-volume manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surfx Technologies.